Viewing Study NCT05201859


Ignite Creation Date: 2025-12-24 @ 2:23 PM
Ignite Modification Date: 2026-01-29 @ 6:28 PM
Study NCT ID: NCT05201859
Status: RECRUITING
Last Update Posted: 2022-05-06
First Post: 2022-01-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Adjuvant Sintilimab Plus Capecitabine in Nasopharyngeal Carcinoma
Sponsor:
Organization: